KAMRAN MANSOURY
*** **** *** ******, ************, IN
Phone: 832-***-****
E-Mail: **************@*****.***
PROFILE
I am a senior project manager, research scientist, and cross functional
leader with 15 years of experience in bio-pharmaceutical industry, and
academia. I have directed clinical development of multi-center programs in
all phases of study life cycle, including start-up, interim, and close out
stage. I have helped in design and clinical development of a novel class of
anti-infective drugs, as well as an anti-infective drug design program for
tuberculosis. I have made significant contributions in managing multi-phase
clinical trials for Solanezumab, Cialis, Alimta, Cymbalta, Zyprexa,
Strattera, Effient, and Axiron, to name a few.
I am proficient in FDA, EMEA, and NIH procedures, rules and regulations, as
well as GCP and ICH. I am also an expert in operations, risk management,
budgeting, forecasting, capacity planning, variance explanations, change
management, plan implementation, cost containing measure, regulatory
submissions, EMR, eCRF InForm Software System for Global Clinical Data
Management and Operations, Planisware and TrackWise softwares. I am
creative, have an analytical mind, and I believe that my combined
personality, back ground and experience make me extremely suited for a
dynamic, positive, and ever-growing organization.
PROFESSIONAL EXPERIENCE
Senior Project Manager
Eli Lilly & Company
January 2012 - Present
- Senior Project Manager at Global Statistical Sciences and Advanced
Analytics
- Responsible for managing activities and resources of multi-
phase/multi-center clinical trials in Neuroscience, Cardiovascular,
and Urology
- Significantly improved departmental efficiency by implementing
internal tracking software, database integrations, and project
management methodologies
- Managing timelines and milestones achievements for multi-center
clinical trials, data locks, data quality and transfers, Trial-Level
Risk Management, annual reports, regulatory submissions, and
regulatory responses, as well as external vendors and contractor's
interactions
- Significantly increased efficiency in clinical timeline management,
by developing a new Tracking database, to better visualize ongoing and
upcoming activities and timelines
- Improved clinical work flow by integrating internal database, to
manage costs, resources and to conduct forecasting
- Planisware software / Business Costing Model data management.
Variance explanation.
- Change management. Database migration from internal forms to
Planisware software
- TrackWise software for Deviation Management and deviation impact
analysis. Risk Mitigation and Management
- SAS Drug Development and SDD Integration Broker software data
sharing. Data Transfer between the companies any collaborators in the
US and Global Affiliates
- Interaction with CRO and TPOs, for U.S., and Global Trials
- CRO trail management, Project related task coordination, conflict
resolution. Bridging sponsor required tasks with CROs in EU, Japan,
and China
- Coordinate creation, analysis and submission of Analytical Data Sets
(ADS), ADS requirements, ADS programming, TFL requirements, TFL
programming and TFL production
- Plan and manage Integrated Data Bases activities, Data Mining,
Statistical Analysis Plan, Abstracts, Manuscripts and Posters related
to clinical studies
- Budgeting, Capacity Planning, Forecasting, Resourcing of different
Programs in the Department
- CROs / external vendor's relations
- System integration of Planisware to track and manage therapeutic
pipeline
- Development of new compound/trials tracking systems and data bases
within the Neuroscience, Cardio Vascular and Urology department
Program Manager, Clinical Development and Management
Global Allied Pharmaceuticals, CRO/BPO Company
July 2008 - December 2011
- Demonstrated a high degree of project management and integrated
project planning skills
- Provide leadership and expertise to project teams responsible for
the clinical development planning of new products
- Interaction with sponsors and clinical teams, thought leads
physician specialists, health economists, and clinical development
consulting groups to provide the best medical/scientific direction and
strategy for each drug candidate indication
- Provide leadership and strategic direction for the development and
execution of multiple clinical programs. Leadership role in
advancing clinical development programs across R&D departments, and
regulatory agencies
- Electronic Medical Record (EMR) use for patient enrollment
- Life cycle management. Leadership role in the review and oversight
of oncology trials globally (Phases I-IV)
- Project planning for protocol writing and reviews, selection of
external resources, assessment of clinical results, review of final
reports, monitoring budget, resources and time lines
- Managed teams to prepare/review clinical documents, including
Protocol, CSR, IND, and NDA
- Leadership role in planning and communicating with Regulators, such
as FDA and EMEA
- Participate with outside consultants in clarifying and defining
efficacy and safety standards for assigned new drug development
programs
- Worked with cross-functional teams to ensure adequate resource
allocation to projects
- Developed/implemented study process documents, monitoring plans,
monitoring reports, and study templates.
- Identified project risks and implemented mitigation strategies
- Identified and qualified investigators, and investigative sites
Research and Development Project Manager / Staff Scientist
Institute Of Biosciences and Technology, Texas A&M University / Houston
Medical Center
July 2006 - July 2008
- Created new and automated data management tools for structure guided
drug design and vaccine development for tuberculosis
- LIMS design and implementation
- Demonstrated successful experience working with complex cross-
functional project team
- Feasibility study for new drug development programs
- Assisted in the management of an active pipeline in pre-clinical
research
- Project Manager and the Scientist in charge of Research and
Development/technology transfer team
- Reviewed protocols, SOPs and ensured adherence to GCP. Worked with
QA on regulatory. Remained current on FDA and NIH rules and
regulations
- A member of International Tuberculosis Structural Genomics
Consortium. A high exposure representative of the team in the cross
functional and joint venture team
Research Project Manager / Scientist 3
AFFINIUM PHARMACEUTICALS / Pfizer Collaboration
June 2001 - July 2006
- Project Coordinator and team member of the Structural Biology Group,
responsible for determination of more than 30 Pfizer/Affinium High
Activity Drug Targets and Fragment Based Drug Design during 3 years of
the two companies' collaboration
- Structure guided drug development and Fragment Based Drug Design
hands on research
- Small molecule development and anti-infective phases I-II trials
- Participated in development of trial plans such as protocol
development, trial strategies, trial budgets, site selection, and
clinical supplies management
- LIMS and automation design, testing, and implementation
- Managing overall site staff, HR, overseeing clinical operations such
as recruiting, sampling and visit scheduling. Site monitoring
experience
- Review of regulatory documents, participated in the development of
draft protocol, template informed consent and study documents. Helped
preparing site coordinators manual, and source documents. Organized
reporting of AEs and SAEs from clinical trials and in accordance with
Company's SOPs and guidelines
Research Associate
MDS PROTEOMICS
August 2000 June 2001
- Small molecules development and design for new oncology drugs
- Data management of protein-protein interactions in several projects,
including the mapping of the yeast Saccharomyces cerevisiae protein
interactions
- LIMS implementation and testing
- Proteomics analysis of millions of DNA sequences, protein
interactions, and Mass Spec. identified protein and gene fragments,
relevant in different cancer research programs world wide
- Helped establishing the tissue culture and mammalian research
laboratory, building the company from a single room into a $350M
venture
1 Research Assistant
2 York University
September 1998 - August 2000
- In this research position at the Laboratory of Sir. Kenneth Davey,
performed extensive research in order to identify Membrane Protein
Receptors for Thyroxine (T3) and Juvenile Hormone on the Follicle
Cells of the insect Lacusta migratoria
- Proof-of-concept experimental design and execution. Generated high
quality experimental data that contributed to publication of number of
research papers in zoological publications
PUBLICATIONS
Co-author of four structure biology papers in bacterial drug targets and
small molecule drugs in Protein Data Bank (NCBI-PDB); Co-author of sixty
four patents in Structure Biology and Structure Guided Drug Design;
Citations in Dawn Webster on Novel Essential Bacterial Polypeptides.
TECHNICAL SKILLS
SAS Drug Development, SDD Integration Broker, Planisware Data Management,
Deviation Management, TrackWise, Critical Chain Project Management, Six
Sigma
Databases: Protein Data Bank, NCBI, PubMed, Entrez, LIMS
Desktop: MS Word, MS PowerPoint, MS Excel, MS Project, Photo shop
EDUCATION
B. Sc., Biology, York University, 2000
Biological Chemical Technology, Seneca College, 1995
REFERENCES
AVAILABLE UPON REQUEST